{"schema_version":"1","generated_at":"2026-10-31T20:58:47.144Z","data_as_of":null,"url":"https://www.findmykol.com/kol/james-felser","json_url":"https://www.findmykol.com/kol/james-felser/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"james-felser","name":"James Felser","credential":"MD","specialty":"Infectious Disease","specialty_raw":"Infectious Disease","therapeutic_area":"Infectious Disease","therapeutic_areas":["Infectious Disease"],"city":"East Hanover","state":"NJ","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1821335043","openalex":"A5054627683"},"summary":"James Felser is an Infectious Disease physician. OpenAlex indexes 26 publications with 1,187 citations (h-index 16).","overview":null,"focus":{"indications":[],"research_topics":["Infectious Disease"]},"scholarship":{"works_count":26,"cited_by_count":1187,"h_index":16,"latest_activity_year":2026,"source":"works"},"publications":{"total":24,"shown":5,"withheld":19,"matched_by":"OpenAlex author record","recent":[{"title":"Inhaled anti-thymic stromal lymphopoietin antibody fragment, ecleralimab, in severe asthma: A placebo-controlled, multicenter, double-blind, randomized, phase 2b clinical trial","year":2026,"journal":"American Journal of Respiratory and Critical Care Medicine","source_url":"https://doi.org/10.1093/ajrccm/aamag123","status":"verified"},{"title":"Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial","year":2022,"journal":"The Lancet Rheumatology","source_url":"https://doi.org/10.1016/s2665-9913(22)00044-3","status":"verified"},{"title":"Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled asthma: the SPIRIT randomised clinical trial","year":2021,"journal":"Respiratory Research","source_url":"https://doi.org/10.1186/s12931-021-01904-8","status":"verified"},{"title":"Long-Term Safety of Fevipiprant (QAW039) in Patients with Asthma, Inadequately Controlled on Standard-of-Care Therapy: Design of The Phase III SPIRIT Trial","year":2019,"source_url":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1314","status":"verified"},{"title":"Long-term safety and efficacy of imatinib in pulmonary arterial hypertension","year":2015,"journal":"The Journal of Heart and Lung Transplantation","source_url":"https://doi.org/10.1016/j.healun.2015.05.025","status":"verified"}],"source":"works"},"contact":{"address_1":"1 HEALTH PLZ","city":"East Hanover","state":"NJ","zip":"079361016","phone":"862-778-7565","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1821335043","source":"identity"},"similar":[{"name":"Thomas Walsh","slug":"thomas-walsh","institution":"Cornell University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/thomas-walsh","json_url":"https://www.findmykol.com/kol/thomas-walsh/profile.json"},{"name":"Douglas Richman","slug":"douglas-richman","institution":"University of California San Diego","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/douglas-richman","json_url":"https://www.findmykol.com/kol/douglas-richman/profile.json"},{"name":"Vance Fowler","slug":"vance-fowler","institution":"Duke University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/vance-fowler","json_url":"https://www.findmykol.com/kol/vance-fowler/profile.json"},{"name":"Myron Cohen","slug":"myron-cohen","institution":"University of North Carolina at Chapel Hill School of Medicine","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/myron-cohen","json_url":"https://www.findmykol.com/kol/myron-cohen/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":19}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2013-01-08","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}